Wang, T., Sun, X., Ding, H., Wang, D., Li, W., Xu, H., . . . Li, H. Tislelizumab as adjuvant therapy following endoscopic surgery for resectable recurrent nasopharyngeal carcinoma: A randomized clinical trial. BMJ Publishing Group.
Chicago Style (17th ed.) CitationWang, Tian, et al. Tislelizumab as Adjuvant Therapy Following Endoscopic Surgery for Resectable Recurrent Nasopharyngeal Carcinoma: A Randomized Clinical Trial. BMJ Publishing Group.
MLA (9th ed.) CitationWang, Tian, et al. Tislelizumab as Adjuvant Therapy Following Endoscopic Surgery for Resectable Recurrent Nasopharyngeal Carcinoma: A Randomized Clinical Trial. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.